Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.
anticoagulants
Pradaxa gives clinicians a new tool for preventing strokes and blood clots in patients with atrial fibrillation. Learn how it works, who’s eligible to receive it, and how…
The American Heart Association (AHA) has released a scientific statement on reversing the effects of non–vitamin K oral anticoagulants. Read more
Brush up on your knowledge of these potentially life-saving drugs.
Mrs. Muriel H, age 78, is admitted to the medical-surgical unit with GI bleeding. She has a 5-year history of atrial fibrillation and has been taking warfarin 5…
A new oral anticoagulant hits the market
Pradaxa gives clinicians a new tool for preventing strokes and blood clots in patients with atrial fibrillation. Learn how it works, who’s eligible to…
AHA releases new guidelines for reversing non–vitamin K oral anticoagulants
The American Heart Association (AHA) has released a scientific statement on reversing the effects of non–vitamin K oral anticoagulants. Read more
Pharmacology review: Drugs that alter blood coagulation
Brush up on your knowledge of these potentially life-saving drugs.
What’s new in anticoagulation for patients with atrial fibrillation?
Mrs. Muriel H, age 78, is admitted to the medical-surgical unit with GI bleeding. She has a 5-year history of atrial fibrillation and has…